{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,22]],"date-time":"2025-11-22T16:30:19Z","timestamp":1763829019148,"version":"3.37.3"},"reference-count":35,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2012,9,1]],"date-time":"2012-09-01T00:00:00Z","timestamp":1346457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,9,1]],"date-time":"2012-09-01T00:00:00Z","timestamp":1346457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["dmd.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism and Disposition"],"published-print":{"date-parts":[[2012,9]]},"DOI":"10.1124\/dmd.112.045500","type":"journal-article","created":{"date-parts":[[2012,6,21]],"date-time":"2012-06-21T13:07:27Z","timestamp":1340284047000},"page":"1846-1853","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Influence of Enterohepatic Recycling on the Time Course of Brain-to-Blood Partitioning of Valproic Acid in Rats"],"prefix":"10.1016","volume":"40","author":[{"given":"Jeannie M.","family":"Padowski","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gary M.","family":"Pollack","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1124\/dmd.112.045500_bib1","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/bdd.259","article-title":"Nonstationary disposition of valproic acid during prolonged intravenous infusion: contributions of unbound clearance and protein binding","volume":"22","author":"Arens","year":"2001","journal-title":"Biopharm Drug Dispos"},{"key":"10.1124\/dmd.112.045500_bib2","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/BF01062139","article-title":"Testing for the equality of area under the curves when using destructive measurement techniques","volume":"16","author":"Bailer","year":"1988","journal-title":"J Pharmacokinet Biopharm"},{"key":"10.1124\/dmd.112.045500_bib3","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1124\/jpet.106.102491","article-title":"Valproic acid is not a substrate for P-glycoprotein or multidrug resistance proteins 1 and 2 in a number of in vitro and in vivo transport assays","volume":"320","author":"Baltes","year":"2007","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/dmd.112.045500_bib4","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1097\/00004647-200002000-00020","article-title":"Development of an in situ mouse brain perfusion model and its application to mdr1a P-glycoprotein-deficient mice","volume":"20","author":"Dagenais","year":"2000","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1124\/dmd.112.045500_bib5","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1006\/taap.1994.1179","article-title":"Development of a physiologically based pharmacokinetic model for perchloroethylene using tissue concentration-time data","volume":"128","author":"Dallas","year":"1994","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1124\/dmd.112.045500_bib6","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.ejpb.2008.05.022","article-title":"Transport of valproate at intestinal epithelial (Caco-2) and brain endothelial (RBE4) cells: mechanism and substrate specificity","volume":"70","author":"Fischer","year":"2008","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1124\/dmd.112.045500_bib7","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1002\/jps.2600580308","article-title":"Effect of mode of administration on drug distribution in a two-compartment open system","volume":"58","author":"Gibaldi","year":"1969","journal-title":"J Pharm Sci"},{"key":"10.1124\/dmd.112.045500_bib8","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1023\/A:1018982300285","article-title":"Assessment of valproic acid serum-cerebrospinal fluid transport by microdialysis","volume":"10","author":"Golden","year":"1993","journal-title":"Pharm Res"},{"key":"10.1124\/dmd.112.045500_bib9","doi-asserted-by":"crossref","first-page":"423","DOI":"10.3109\/00498258709043949","article-title":"Effects of antibiotic pretreatments on the metabolism and excretion of [U14C](+)-catechin [(U14C](+)-cyanidanol-3) and its metabolite, 3\u2032-0-methyl-(+)-catechin","volume":"17","author":"Gott","year":"1987","journal-title":"Xenobiotica"},{"key":"10.1124\/dmd.112.045500_bib10","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0090-9556(25)08283-2","article-title":"Disposition and protein binding of valproic acid in the developing rat","volume":"22","author":"Haberer","year":"1994","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.112.045500_bib11","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1023\/A:1012080106490","article-title":"Drug equilibration across the blood-brain barrier\u2014pharmacokinetic considerations based on the microdialysis method","volume":"14","author":"Hammarlund-Udenaes","year":"1997","journal-title":"Pharm Res"},{"key":"10.1124\/dmd.112.045500_bib12","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0006-8993(82)90664-3","article-title":"In vivo uptake of valproic acid into brain","volume":"240","author":"Hammond","year":"1982","journal-title":"Brain Res"},{"key":"10.1124\/dmd.112.045500_bib13","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/j.1748-1716.1979.tb06455.x","article-title":"Estimation of cerebral extraction of circulating compounds by the brain uptake index method: influence of circulation time, volume injection, and cerebral blood flow","volume":"107","author":"Hardebo","year":"1979","journal-title":"Acta Physiol Scand"},{"key":"10.1124\/dmd.112.045500_bib14","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s11095-006-9135-x","article-title":"Kinetic considerations for the quantitative assessment of efflux activity and inhibition: implications for understanding and predicting the effects of efflux inhibition","volume":"24","author":"Kalvass","year":"2007","journal-title":"Pharm Res"},{"key":"10.1124\/dmd.112.045500_bib15","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1002\/bdd.563","article-title":"Influence of chronic hepatic failure on disposition kinetics of valproate excretion through a phase II reaction in rats treated with carbon tetrachloride","volume":"28","author":"Khemawoot","year":"2007","journal-title":"Biopharm Drug Dispos"},{"key":"10.1124\/dmd.112.045500_bib16","doi-asserted-by":"crossref","first-page":"3136","DOI":"10.1128\/AAC.42.12.3136","article-title":"Possible mechanism by which the carbapenem antibiotic panipenem decreases the concentration of valproic acid in plasma in rats","volume":"42","author":"Kojima","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1124\/dmd.112.045500_bib17","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1007\/BF01062545","article-title":"In vitro and in vivo evaluation of the tissue-to-blood partition coefficient for physiological pharmacokinetic models","volume":"10","author":"Lin","year":"1982","journal-title":"J Pharmacokinet Biopharm"},{"key":"10.1124\/dmd.112.045500_bib18","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/S0090-9556(25)08799-9","article-title":"Pharmacokinetics and pharmacodynamics of valproate analogs in rats. III. Pharmacokinetics of valproic acid, cyclohexanecarboxylic acid, and 1-methyl-1-cyclohexanecarboxylic acid in the bile-exteriorized rat","volume":"20","author":"Liu","year":"1992","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.112.045500_bib19","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1002\/bdd.2510140406","article-title":"Pharmacokinetics and pharmacodynamics of valproate analogs in rats. II. Pharmacokinetics of octanoic acid, cyclohexanecarboxylic acid, and 1-methyl-1-cyclohexanecarboxylic acid","volume":"14","author":"Liu","year":"1993","journal-title":"Biopharm Drug Dispos"},{"key":"10.1124\/dmd.112.045500_bib20","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1111\/j.1528-1157.1994.tb02939.x","article-title":"Pharmacokinetics and pharmacodynamics of valproate analogues in rats. IV. Anticonvulsant action and neurotoxicity of octanoic acid, cyclohexanecarboxylic acid, and 1-methyl-1-cyclohexanecarboxylic acid","volume":"35","author":"Liu","year":"1994","journal-title":"Epilepsia"},{"key":"10.1124\/dmd.112.045500_bib21","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1124\/jpet.104.079319","article-title":"Use of a physiologically based pharmacokinetic model to study the time to reach brain equilibrium: an experimental analysis of the role of blood-brain barrier permeability, plasma protein binding, and brain tissue binding","volume":"313","author":"Liu","year":"2005","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/dmd.112.045500_bib22","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/j.neuropharm.2010.01.007","article-title":"Evaluation of transport of common antiepileptic drugs by human multidrug resistance-associated proteins (MRP1, 2 and 5) that are overexpressed in pharmacoresistant epilepsy","volume":"58","author":"Luna-Tort\u00f3s","year":"2010","journal-title":"Neuropharmacology"},{"key":"10.1124\/dmd.112.045500_bib23","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1080\/15563650802178136","article-title":"Valproic acid poisoning: an evidence-based consensus guideline for out-of-hospital management","volume":"46","author":"Manoguerra","year":"2008","journal-title":"Clin Toxicol (Phila)"},{"key":"10.1124\/dmd.112.045500_bib24","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1124\/dmd.104.000661","article-title":"Mechanism of the drug interaction between valproic acid and carbapenem antibiotics in monkeys and rats","volume":"32","author":"Nakajima","year":"2004","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.112.045500_bib25","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/BF00613825","article-title":"Effect of activated charcoal on absorption of tolbutamide and valproate in man","volume":"24","author":"Neuvonen","year":"1983","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1124\/dmd.112.045500_bib26","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1007\/s10928-011-9218-0","article-title":"The influence of distributional kinetics into a peripheral compartment on the pharmacokinetics of substrate partitioning between blood and brain tissue","volume":"38","author":"Padowski","year":"2011","journal-title":"J Pharmacokinet Pharmacodyn"},{"key":"10.1124\/dmd.112.045500_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.brainres.2011.10.009","article-title":"Influence of time to achieve substrate distribution equilibrium between brain tissue and blood on quantitation of the blood-brain barrier P-glycoprotein effect","volume":"1426","author":"Padowski","year":"2011","journal-title":"Brain Res"},{"key":"10.1124\/dmd.112.045500_bib28","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/BF01073869","article-title":"Physiologic and metabolic influences on enterohepatic recirculation: simulations based upon the disposition of valproic acid in the rat","volume":"19","author":"Pollack","year":"1991","journal-title":"J Pharmacokinet Biopharm"},{"key":"10.1124\/dmd.112.045500_bib29","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1021\/mp0500871","article-title":"P-glycoprotein recognition of substrates and circumvention through rational drug design","volume":"3","author":"Raub","year":"2006","journal-title":"Mol Pharm"},{"key":"10.1124\/dmd.112.045500_bib30","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1124\/jpet.107.121525","article-title":"Central nervous system drug disposition: the relationship between in situ brain permeability and brain free fraction","volume":"322","author":"Summerfield","year":"2007","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/dmd.112.045500_bib31","first-page":"3752","article-title":"Involvement of beta-glucuronidase in intestinal microflora in the intestinal toxicity of the antitumor camptothecin derivative irinotecan hydrochloride (CPT-11) in rats","volume":"56","author":"Takasuna","year":"1996","journal-title":"Cancer Res"},{"key":"10.1124\/dmd.112.045500_bib32","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1007\/s00280-006-0187-8","article-title":"Optimal antidiarrhea treatment for antitumor agent irinotecan hydrochloride (CPT-11)-induced delayed diarrhea","volume":"58","author":"Takasuna","year":"2006","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1124\/dmd.112.045500_bib33","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/S0022-3565(25)20513-4","article-title":"Transport of monocarboxylic acids at the blood-brain barrier: studies with monolayers of primary cultured bovine brain capillary endothelial cells","volume":"258","author":"Terasaki","year":"1991","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/dmd.112.045500_bib34","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1124\/jpet.103.064220","article-title":"Abolition of valproate-derived choleresis in the Mrp2 transporter-deficient rat","volume":"310","author":"Wright","year":"2004","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/dmd.112.045500_bib35","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1007\/s10439-010-9920-x","article-title":"Effect of surface charge of immortalized mouse cerebral endothelial cell monolayer on transport of charged solutes","volume":"38","author":"Yuan","year":"2010","journal-title":"Ann Biomed Eng"}],"container-title":["Drug Metabolism and Disposition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624227938?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624227938?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/dmd.112.045500","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T20:13:21Z","timestamp":1739909601000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090955624227938"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9]]},"references-count":35,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2012,9]]}},"alternative-id":["S0090955624227938"],"URL":"https:\/\/doi.org\/10.1124\/dmd.112.045500","relation":{},"ISSN":["0090-9556"],"issn-type":[{"type":"print","value":"0090-9556"}],"subject":[],"published":{"date-parts":[[2012,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Influence of Enterohepatic Recycling on the Time Course of Brain-to-Blood Partitioning of Valproic Acid in Rats","name":"articletitle","label":"Article Title"},{"value":"Drug Metabolism and Disposition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/dmd.112.045500","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2012 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}